On 2025-05-06, Denali Therapeutics Inc. (DNLI) announced earnings per share of $-0.78 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.71.
The next expected annoucement date for quarterly earnings is 2025-08-07, with an average estimated earnings per share of $-0.73 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-0.71 | $-0.78 |
| 2025-02-27 | 2024-12-31 | $-0.83 | $-0.67 |
| 2024-11-06 | 2024-09-30 | $-0.60 | $-0.63 |
| 2024-08-01 | 2024-06-30 | $-0.68 | $-0.59 |
| 2024-05-07 | 2024-03-31 | $-0.67 | $-0.68 |
| 2024-02-27 | 2023-12-31 | $-0.82 | $-0.86 |
| 2023-11-07 | 2023-09-30 | $-0.83 | $-0.72 |
| 2023-08-08 | 2023-06-30 | $-0.86 | $1.30 |
| 2023-05-08 | 2023-03-31 | $-0.71 | $-0.80 |
| 2023-02-27 | 2022-12-31 | $-0.78 | $-0.75 |
| 2022-11-03 | 2022-09-30 | $-0.83 | $-0.84 |
| 2022-08-08 | 2022-06-30 | $-0.52 | $-0.48 |
| 2022-05-05 | 2022-03-31 | $-0.47 | $-0.53 |
| 2022-02-28 | 2021-12-31 | $-0.41 | $-0.62 |
| 2021-11-04 | 2021-09-30 | $-0.51 | $-0.69 |
| 2021-08-04 | 2021-06-30 | $-0.37 | $-0.50 |
| 2021-05-03 | 2021-03-31 | $-0.37 | $-0.58 |
| 2021-02-25 | 2020-12-31 | $-0.55 | $1.91 |
| 2020-11-05 | 2020-09-30 | $3.57 | $-0.54 |
| 2020-08-07 | 2020-06-30 | $-0.61 | $-0.56 |
| 2020-05-07 | 2020-03-31 | $-0.57 | $-0.55 |
| 2020-02-27 | 2019-12-31 | $-0.53 | $-0.56 |
| 2019-11-06 | 2019-09-30 | $-0.53 | $-0.48 |
| 2019-08-06 | 2019-06-30 | $-0.46 | $-0.61 |
| 2019-05-08 | 2019-03-31 | $-0.37 | $-0.41 |
| 2019-03-12 | 2018-12-31 | $-0.02 | $0.79 |
| 2018-11-08 | 2018-09-30 | $-0.21 | $-0.38 |
| 2018-08-09 | 2018-06-30 | $-0.19 | $-0.59 |
| 2018-05-11 | 2018-03-31 | $-0.03 | $-0.26 |
| 2018-03-19 | 2017-12-31 | $-0.30 | $-0.74 |